Beyond Weight Loss: GLP-1 Drugs Enter the Eating Disorder Conversation
By Irene Yeh Originally developed to treat type 2 diabetes and later for obesity management, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are rapidly expanding into other areas of treatment. Researchers...
Read More
Fresh Insights on What Helps Patient Recovery in the ICU
By Deborah Borfitz The findings of more than 150 randomized controlled trials provide ample evidence that early mobilization of patients with acute respiratory failure (ARF) in the intensive care unit...
Read More
Follow the Money: SARM1 Inhibitor for ALS, Mental Health, AI
By Integrative Practitioner Staff Handspring grows its workforce, partnerships, and reach to offer virtual mental health treatment for youth and families; Supply6 plans to enhance its product innovation, clinical research,...
Read More
Vibrating Pill Could Both Treat Eating Disorders and Predict Relapse
By Deborah Borfitz Digestive sensations profoundly affect mental health through the bidirectional gut-brain axis, and in the case of anorexia nervosa (AN) tends to do so at crisis proportions. The disorder has one of...
Read More
Fluorescent Nanosensor Offers Rapid Way to Measure Gut Health Biomarker
By Integrative Practitioner Staff Researchers from the Singapore-MIT Alliance for Research and Technology (SMART) and the National Institute of Education (NIE), Nanyang Technological University, Singapore (NTU Singapore) have developed a...
Read More
Traditional Chinese Medicine May Help Relieve Long COVID Symptoms
By Irene Yeh The World Health Organization (WHO) defines long COVID as persistent symptoms of the COVID-19 virus that occur three months after initial infection. Symptoms last at least two months and...
Read More
No Such Thing as “Moderate” with Alcohol Consumption
By Irene Yeh Alcohol consumption remains one of the leading causes of disease and death in the U.S., yet there is still limited knowledge about how much drinking can truly...
Read More
New Alzheimer’s Blood Test Flags Symptom Onset
By Allison Proffitt Researchers from Washington University School of Medicine, St. Louis have showed that elevated levels of a set of circular RNAs (circRNAs) in the blood nearly tripled patients’ risk of developing Alzheimer’s Disease (AD) symptoms, suggesting...
Read More